Cargando…

Effect of Combined Use of Astragaloside IV (AsIV) and Atorvastatin (AV) on Expression of PPAR-γ and Inflammation-Associated Cytokines in Atherosclerosis Rats

BACKGROUND: The aim of this study was to assess the effect of combined use of Astragaloside IV(AsIV) and atorvastatin (AV) on the expression of PPAR-γ and inflammation-associated cytokines in atherosclerosis rats. MATERIAL/METHODS: High-density lipoprotein cholesterol (HDL-C), total cholesterol (TC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Bin, Rui, Ruping, Pan, Haiying, Zhang, Luchang, Wang, Xiaolong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2018
Materias:	Animal Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139110/ https://www.ncbi.nlm.nih.gov/pubmed/30190450 http://dx.doi.org/10.12659/MSM.908480

Ejemplares similares

Astragaloside IV Alleviates Lipopolysaccharide-Induced Acute Kidney Injury Through Down-Regulating Cytokines, CCR5 and p-ERK, and Elevating Anti-Oxidative Ability
por: Zhou, Wei, et al.
Publicado: (2017)

Astragaloside IV regulates autophagy-mediated proliferation and apoptosis in a rat model of PCOS by activating the PPARγ pathway
por: Wen, Mingxiao, et al.
Publicado: (2022)

Protective Effects of Astragaloside IV Combined with Budesonide in Bronchitis in Rats by Regulation of Nrf2/Keap1 Pathway
por: Zhang, Zhijie, et al.
Publicado: (2018)

Anticancer effects and mechanisms of astragaloside-IV
por: Zhou, Liangxing, et al.
Publicado: (2022)

Astragaloside IV alleviates placental oxidative stress and inflammation in GDM mice
por: Zhou, Ling, et al.
Publicado: (2020)

Effects of Astragaloside IV on heart failure in rats
por: Zhao, Zhuanyou, et al.
Publicado: (2009)

Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
por: Liu, Wei, et al.
Publicado: (2019)

Astragaloside IV, as a potential anticancer agent
por: Xia, Dongqin, et al.
Publicado: (2023)

Pharmacological Effects of Astragaloside IV: A Review
por: Liang, Yutong, et al.
Publicado: (2023)

Astragaloside IV Alleviates the Myocardial Damage Induced by Lipopolysaccharide via the Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB)/Proliferator-Activated Receptor α (PPARα) Signaling Pathway
por: Zhang, Xiaoyao, et al.
Publicado: (2019)

Review of the pharmacological effects of astragaloside IV and its autophagic mechanism in association with inflammation
por: Yang, Ying, et al.
Publicado: (2022)

The mechanism of astragaloside IV promoting sciatic nerve regeneration
por: Zhang, Xiaohong, et al.
Publicado: (2013)

Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
por: Tan, Yu-Qing, et al.
Publicado: (2020)

Molecular mechanisms of astragaloside-IV in cancer therapy (Review)
por: Chen, Tianqi, et al.
Publicado: (2021)

Roles and Mechanisms of Astragaloside IV in Combating Neuronal Aging
por: Zaman, Qumar, et al.
Publicado: (2022)

Research progress on the mechanism of astragaloside IV in the treatment of asthma
por: Yuan, Fanyi, et al.
Publicado: (2023)

Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation
por: Zhang, Yudi, et al.
Publicado: (2020)

Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation
por: Dong, Zhiwei, et al.
Publicado: (2017)

Effects of Astragaloside IV on the SDF-1/CXCR4 Expression in Atherosclerosis of apoE(−/−) Mice Induced by Hyperlipaemia
por: Qin, Hewei, et al.
Publicado: (2015)

Astragaloside IV ameliorates renal injury in db/db mice
por: Sun, Huili, et al.
Publicado: (2016)

Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease
por: Xia, Mei-Ling, et al.
Publicado: (2020)

Evaluation of astragaloside IV in hepatic fibrosis: A meta-analysis
por: Han, Zhongying, et al.
Publicado: (2021)

Astragaloside IV alleviates heart failure by modulating Nrf-2
por: Feng, Wenxiao, et al.
Publicado: (2022)

Pharmacokinetic study on the co-administration of abemaciclib and astragaloside IV in rats
por: Sun, Sen, et al.
Publicado: (2022)

Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases
por: Tan, Junlan, et al.
Publicado: (2023)

Review on the protective mechanism of astragaloside IV against cardiovascular diseases
por: Yang, Chunkun, et al.
Publicado: (2023)

Astragaloside IV ameliorates allergic inflammation by inhibiting key initiating factors in the initial stage of sensitization
por: Bao, Kai-fan, et al.
Publicado: (2016)

Astragaloside IV improves renal function and alleviates renal damage and inflammation in rats with chronic glomerulonephritis
por: ZHANG, Dong, et al.
Publicado: (2022)

Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR(−/−) Mice
por: Zhang, Yifan, et al.
Publicado: (2022)

Gastroprotective Effects of Astragaloside IV against Acute Gastric Lesion in Rats
por: Mao, Shuai, et al.
Publicado: (2016)

Protective Effects of Astragaloside IV on db/db Mice with Diabetic Retinopathy
por: Ding, Yuzhi, et al.
Publicado: (2014)

Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts
por: Wang, Zhen-Fei, et al.
Publicado: (2017)

Astragaloside IV protects RGC-5 cells against oxidative stress
por: Hao, Ming, et al.
Publicado: (2018)

Protective Effect of Astragaloside IV on Hepatic Injury Induced by Iron Overload
por: Xie, Dongyu, et al.
Publicado: (2019)

Effects of puerarin on the pharmacokinetics of astragaloside IV in rats and its potential mechanism
por: Zhang, Huan, et al.
Publicado: (2020)

Astragaloside IV alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo
por: Wu, Suxiao, et al.
Publicado: (2019)

Influence of astragaloside IV on pharmacokinetics of triptolide in rats and its potential mechanism
por: Gao, Jian, et al.
Publicado: (2020)

Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy
por: Luo, Li-Fei, et al.
Publicado: (2021)

Regulatory Effects of Astragaloside IV on Hyperglycemia-Induced Mitophagy in Schwann Cells
por: Wei, Xiaoyi, et al.
Publicado: (2022)

The Astragaloside IV Derivative LS-102 Ameliorates Obesity-Related Nephropathy
por: Li, Ziyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p0obog3iss9ukvrpg7uii56jnm